These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 31165158)

  • 1. Comparative Validation of Breast Cancer Risk Prediction Models and Projections for Future Risk Stratification.
    Pal Choudhury P; Wilcox AN; Brook MN; Zhang Y; Ahearn T; Orr N; Coulson P; Schoemaker MJ; Jones ME; Gail MH; Swerdlow AJ; Chatterjee N; Garcia-Closas M
    J Natl Cancer Inst; 2020 Mar; 112(3):278-285. PubMed ID: 31165158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 10-year performance of four models of breast cancer risk: a validation study.
    Terry MB; Liao Y; Whittemore AS; Leoce N; Buchsbaum R; Zeinomar N; Dite GS; Chung WK; Knight JA; Southey MC; Milne RL; Goldgar D; Giles GG; McLachlan SA; Friedlander ML; Weideman PC; Glendon G; Nesci S; Andrulis IL; John EM; Phillips KA; Daly MB; Buys SS; Hopper JL; MacInnis RJ
    Lancet Oncol; 2019 Apr; 20(4):504-517. PubMed ID: 30799262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative validation of the BOADICEA and Tyrer-Cuzick breast cancer risk models incorporating classical risk factors and polygenic risk in a population-based prospective cohort of women of European ancestry.
    Pal Choudhury P; Brook MN; Hurson AN; Lee A; Mulder CV; Coulson P; Schoemaker MJ; Jones ME; Swerdlow AJ; Chatterjee N; Antoniou AC; Garcia-Closas M
    Breast Cancer Res; 2021 Feb; 23(1):22. PubMed ID: 33588869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of breast cancer risk assessment tools on a French-Canadian population-based cohort.
    Jantzen R; Payette Y; de Malliard T; Labbé C; Noisel N; Broët P
    BMJ Open; 2021 Apr; 11(4):e045078. PubMed ID: 33846154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective evaluation of a breast-cancer risk model integrating classical risk factors and polygenic risk in 15 cohorts from six countries.
    Hurson AN; Pal Choudhury P; Gao C; Hüsing A; Eriksson M; Shi M; Jones ME; Evans DGR; Milne RL; Gaudet MM; Vachon CM; Chasman DI; Easton DF; Schmidt MK; Kraft P; Garcia-Closas M; Chatterjee N;
    Int J Epidemiol; 2022 Jan; 50(6):1897-1911. PubMed ID: 34999890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case-control study.
    Zhang X; Rice M; Tworoger SS; Rosner BA; Eliassen AH; Tamimi RM; Joshi AD; Lindstrom S; Qian J; Colditz GA; Willett WC; Kraft P; Hankinson SE
    PLoS Med; 2018 Sep; 15(9):e1002644. PubMed ID: 30180161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance.
    Quante AS; Whittemore AS; Shriver T; Strauch K; Terry MB
    Breast Cancer Res; 2012 Nov; 14(6):R144. PubMed ID: 23127309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective validation of the NCI Breast Cancer Risk Assessment Tool (Gail Model) on 40,000 Australian women.
    Nickson C; Procopio P; Velentzis LS; Carr S; Devereux L; Mann GB; James P; Lee G; Wellard C; Campbell I
    Breast Cancer Res; 2018 Dec; 20(1):155. PubMed ID: 30572910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simplified Breast Risk Tool Integrating Questionnaire Risk Factors, Mammographic Density, and Polygenic Risk Score: Development and Validation.
    Rosner B; Tamimi RM; Kraft P; Gao C; Mu Y; Scott C; Winham SJ; Vachon CM; Colditz GA
    Cancer Epidemiol Biomarkers Prev; 2021 Apr; 30(4):600-607. PubMed ID: 33277321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the prognostic performance of a polygenic risk score for breast cancer risk stratification.
    Olsen M; Fischer K; Bossuyt PM; Goetghebeur E
    BMC Cancer; 2021 Dec; 21(1):1351. PubMed ID: 34930164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polygenic risk scores for prediction of breast cancer in Korean women.
    Jee YH; Ho WK; Park S; Easton DF; Teo SH; Jung KJ; Kraft P
    Int J Epidemiol; 2023 Jun; 52(3):796-805. PubMed ID: 36343017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating breast cancer risk projections for Hispanic women.
    Banegas MP; Gail MH; LaCroix A; Thompson B; Martinez ME; Wactawski-Wende J; John EM; Hubbell FA; Yasmeen S; Katki HA
    Breast Cancer Res Treat; 2012 Feb; 132(1):347-53. PubMed ID: 22147080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the breast cancer surveillance consortium model of breast cancer risk.
    Tice JA; Bissell MCS; Miglioretti DL; Gard CC; Rauscher GH; Dabbous FM; Kerlikowske K
    Breast Cancer Res Treat; 2019 Jun; 175(2):519-523. PubMed ID: 30796654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a Breast Cancer Risk Prediction Model Incorporating Polygenic Risk Scores and Nongenetic Risk Factors for Korean Women.
    Choi J; Ha TW; Choi HM; Lee HB; Shin HC; Chung W; Han W
    Cancer Epidemiol Biomarkers Prev; 2023 Sep; 32(9):1182-1189. PubMed ID: 37310812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Projecting Individualized Absolute Invasive Breast Cancer Risk in US Hispanic Women.
    Banegas MP; John EM; Slattery ML; Gomez SL; Yu M; LaCroix AZ; Pee D; Chlebowski RT; Hines LM; Thompson CA; Gail MH
    J Natl Cancer Inst; 2017 Feb; 109(2):. PubMed ID: 28003316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing breast cancer risk models in Marin County, a population with high rates of delayed childbirth.
    Powell M; Jamshidian F; Cheyne K; Nititham J; Prebil LA; Ereman R
    Clin Breast Cancer; 2014 Jun; 14(3):212-220.e1. PubMed ID: 24461459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants.
    Evans DGR; Harkness EF; Brentnall AR; van Veen EM; Astley SM; Byers H; Sampson S; Southworth J; Stavrinos P; Howell SJ; Maxwell AJ; Howell A; Newman WG; Cuzick J
    Breast Cancer Res Treat; 2019 Jul; 176(1):141-148. PubMed ID: 30941651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and external validation of a breast cancer absolute risk prediction model in Chinese population.
    Han Y; Lv J; Yu C; Guo Y; Bian Z; Hu Y; Yang L; Chen Y; Du H; Zhao F; Wen W; Shu XO; Xiang Y; Gao YT; Zheng W; Guo H; Liang P; Chen J; Chen Z; Huo D; Li L;
    Breast Cancer Res; 2021 May; 23(1):62. PubMed ID: 34051827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gail model for prediction of absolute risk of invasive breast cancer: independent evaluation in the Florence-European Prospective Investigation Into Cancer and Nutrition cohort.
    Decarli A; Calza S; Masala G; Specchia C; Palli D; Gail MH
    J Natl Cancer Inst; 2006 Dec; 98(23):1686-93. PubMed ID: 17148770
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.